The Bioresearch Monitoring (BIMO) Program, operated by the U.S. Food and Drug Administration (FDA), conducts on-site inspections and data audits in order to effectively monitor the compliance of all ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback